Literature DB >> 21913909

Treatment with tocilizumab leads to the disappearance of olecranon rheumatoid nodules.

Haider M Al Attia1, Mohamed Abushawish.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21913909     DOI： 10.1111/j.1365-4632.2011.04966.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN： 0011-9059            Impact factor:   2.736


× No keyword cloud information.
  3 in total

Review 1.  Paradoxical reactions under TNF-α blocking agents and other biological agents given for chronic immune-mediated diseases: an analytical and comprehensive overview.

Authors:  Éric Toussirot; François Aubin
Journal:  RMD Open       Date:  2016-07-15

2.  Outcomes and Complications of Corticosteroid Injection of Rheumatoid Nodules.

Authors:  Angie Ariza-Hutchinson; Rosemina A Patel; N Suzanne Emil; Maheswari Muruganandam; Sharon E Nunez; Matthew K McElwee; Frank X O'Sullivan; Roderick A Fields; William A Hayward; Luke J Haseler; Wilmer L Sibbitt
Journal:  J Clin Aesthet Dermatol       Date:  2022-08

3.  Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series.

Authors:  Rossella Talotta; Fabiola Atzeni; Alberto Batticciotto; Maria Chiara Ditto; Maria Chiara Gerardi; Piercarlo Sarzi-Puttini
Journal:  J Med Case Rep       Date:  2018-06-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.